FAZAMBIQ Trademark

Trademark Overview

On Wednesday, March 18, 2020, a trademark application was filed for FAZAMBIQ with the United States Patent and Trademark Office. The USPTO has given the FAZAMBIQ trademark a serial number of 88839678. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 16, 2023. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The FAZAMBIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain
fazambiq

General Information

Serial Number88839678
Word MarkFAZAMBIQ
Filing DateWednesday, March 18, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 23, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, October 16, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 8, 2023SOU EXTENSION 5 GRANTED
Thursday, February 16, 2023SOU EXTENSION 5 FILED
Friday, March 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 16, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2022SOU EXTENSION 4 GRANTED
Monday, August 8, 2022SOU EXTENSION 4 FILED
Monday, August 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 23, 2022SOU EXTENSION 3 GRANTED
Wednesday, February 23, 2022SOU EXTENSION 3 FILED
Wednesday, February 23, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2021SOU EXTENSION 2 GRANTED
Monday, August 23, 2021SOU EXTENSION 2 FILED
Monday, August 23, 2021SOU TEAS EXTENSION RECEIVED
Friday, February 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 24, 2021SOU EXTENSION 1 GRANTED
Wednesday, February 24, 2021SOU EXTENSION 1 FILED
Wednesday, February 24, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 12, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 12, 2020EXAMINER'S AMENDMENT ENTERED
Friday, June 12, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 12, 2020EXAMINERS AMENDMENT E-MAILED
Friday, June 12, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 9, 2020ASSIGNED TO EXAMINER
Monday, March 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 21, 2020NEW APPLICATION ENTERED

Related Keywords

fazambiq pain treatment preparations pharmaceutical